Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint InhibitorsWenwen Wang, Lei Chen, Yan Zhao et al.|Advanced Science|2022Cited by 71
Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactionsYanjing Zhu, Lei Chen, Shijie Tang et al.|Cell Reports Medicine|2024Cited by 20
Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary TumorsWenwen Wang, Lei Chen, Lili Ma et al.|Engineering|2022Cited by 5